person · Reporting owner
Cembrero Saralegui Borja
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| My Size, Inc.MYSZ · Entity 8556 | Chief Growth Officer | December 15, 2025 | December 17, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
My Size, Inc.
Report date December 15, 2025 · Filed December 17, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 117,965 |
Reported balance
After 2025-12-15 transaction · row 1
1 source rowRow 1 · 2025-12-15 · Grant · Acquired 110,000 · Balance 117,965 F1: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan"). F2: 10,000 restricted shares vest upon grant date. F3: 40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date. F4: Up to 60,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan").
F2: 10,000 restricted shares vest upon grant date.
F3: 40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date.
F4: Up to 60,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2025 Filed Dec 17, 2025 21:15 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantCommon Stock | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028146 · ownership.xml · nonDerivative · entry 1 Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,965 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan"). F2 · shares: 10,000 restricted shares vest upon grant date. F3 · shares: 40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date. F4 · shares: Up to 60,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 2,500 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014031 · ownership.xml · derivative · entry 4 Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock, $.001 par value per share · 2,500 shares Expires 2029-02-14 F3 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F2 · derivative.exercise_date: The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of February 14, 2025, February 14, 2026 and February 14, 2027, subject to the Reporting Person's continued service. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 2,500 | Not disclosed Strike: $3.83 | Not disclosed |
DisclosureSEC source: 0001641172-25-014031 · ownership.xml · derivative · entry 3 Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 2,500 shares Expires 2029-02-14 F3 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F2 · derivative.exercise_date: The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of February 14, 2025, February 14, 2026 and February 14, 2027, subject to the Reporting Person's continued service. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 1,688 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014031 · ownership.xml · derivative · entry 2 Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,688 Underlying: Common Stock, $.001 par value per share · 1,688 shares Expires 2028-07-13 F3 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of July 13, 2024, July 13, 2025 and July 13, 2026, subject to the Reporting Person's continued service. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,688 | Not disclosed Strike: $8.72 | Not disclosed |
DisclosureSEC source: 0001641172-25-014031 · ownership.xml · derivative · entry 1 Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,688 shares Expires 2028-07-13 F3 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of July 13, 2024, July 13, 2025 and July 13, 2026, subject to the Reporting Person's continued service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.